- Home
- ASTH vs BBOT Comparison
ASTH vs BBOT Comparison
Compare ASTH & BBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASTH | BBOT |
|---|---|---|
| Founded | 1994 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.1B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASTH | BBOT |
|---|---|---|
| Price | $23.86 | $8.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 7 |
| Target Price | ★ $34.00 | $24.00 |
| AVG Volume (30 Days) | ★ 479.2K | 196.1K |
| Earning Date | 03-02-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.46 | N/A |
| Revenue | ★ $519,907,752.00 | N/A |
| Revenue This Year | $27.32 | N/A |
| Revenue Next Year | $10.84 | N/A |
| P/E Ratio | $52.61 | ★ N/A |
| Revenue Growth | ★ 45.90 | N/A |
| 52 Week Low | $18.08 | $8.70 |
| 52 Week High | $34.80 | $14.87 |
Technical Indicators
Market Signals| Indicator | ASTH | BBOT |
|---|---|---|
| Relative Strength Index (RSI) | 53.05 | 34.92 |
| Support Level | $23.14 | N/A |
| Resistance Level | $27.01 | $12.36 |
| Average True Range (ATR) | 1.35 | 0.58 |
| MACD | 0.06 | -0.06 |
| Stochastic Oscillator | 31.14 | 0.85 |
Price Performance
Historical ComparisonAbout ASTH Astrana Health Inc.
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.
About BBOT BridgeBio Oncology Therapeutics Inc.
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.